Chisei Ra Selected Research

IgE Receptors (Fc epsilon RI)

3/2010	Abrogation of high-affinity IgE receptor-mediated mast cell activation at the effector phase prevents contact hypersensitivity to oxazolone.
6/2009	Hyperexpression of the high-affinity IgE receptor-beta chain in chronic allergic keratoconjunctivitis.
7/2005	Expression of Fc(epsilon)RI on dendritic cell subsets in peripheral blood of patients with atopic dermatitis and allergic asthma.
2/2005	FHL3 negatively regulates human high-affinity IgE receptor beta-chain gene expression by acting as a transcriptional co-repressor of MZF-1.
9/2003	Regulation of the human high affinity IgE receptor beta-chain gene expression via an intronic element.
7/2002	High level of Fc epsilon receptor I-bindable immunoglobulin E in the tear fluid and increased immunoglobulin E-saturated cells in the giant papillae of vernal keratoconjunctivitis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chisei Ra Research Topics

Disease

19	Hypersensitivity (Allergy) 09/2013 - 05/2002
12	Asthma (Bronchial Asthma) 05/2014 - 08/2002
9	Inflammation (Inflammations) 07/2013 - 05/2002
6	Atopic Dermatitis (Atopic Eczema) 11/2012 - 01/2002
4	Neoplasms (Cancer) 12/2012 - 10/2005
3	Chronic Urticaria 07/2019 - 01/2013
3	Rheumatoid Arthritis 09/2016 - 11/2007
3	Contact Dermatitis (Eczema, Contact) 03/2015 - 03/2010
3	Melanoma (Melanoma, Malignant) 03/2013 - 08/2012
3	Anaphylaxis (Anaphylactic Shock) 01/2012 - 07/2009
3	Immune System Diseases (Immune Disorders) 12/2010 - 10/2002
3	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 06/2009 - 07/2002
3	Leukemia 10/2008 - 10/2002
2	Osteoarthritis 09/2016 - 01/2013
2	Allergic Contact Dermatitis 03/2015 - 03/2010
2	type 2C Congenital disorder of glycosylation 03/2013 - 01/2013
2	Glomerulonephritis 11/2011 - 01/2008
2	Carcinogenesis 08/2010 - 10/2005
2	Airway Remodeling 11/2009 - 08/2002
2	Proteinuria 01/2008 - 06/2002
2	Hyperplasia 12/2007 - 02/2002
2	Infections 12/2006 - 01/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2004 - 12/2002
2	Autoimmune Diseases (Autoimmune Disease) 10/2002 - 06/2002
1	Experimental Arthritis 07/2013
1	Arthritis (Polyarthritis) 07/2013
1	Mastocytosis 03/2013
1	Cutaneous Mastocytosis 03/2013
1	Myelitis 01/2013
1	Body Weight (Weight, Body) 01/2012
1	Lupus Nephritis 01/2012
1	Respiratory Tract Infections (Respiratory Tract Infection) 11/2009
1	Metaplasia 11/2009
1	Urticaria (Hives) 07/2009
1	Necrosis 07/2009
1	Exercise-Induced Allergies 07/2009
1	Food Hypersensitivity (Food Allergy) 07/2009

Drug/Important Bio-Agent (IBA)

25	Immunoglobulin E (IgE)IBA 07/2019 - 07/2002
7	CytokinesIBA 07/2013 - 01/2002
6	AllergensIBA 03/2015 - 01/2007
6	IgE Receptors (Fc epsilon RI)IBA 03/2010 - 07/2002
5	LigandsIBA 03/2013 - 10/2002
4	DNA (Deoxyribonucleic Acid)IBA 11/2012 - 12/2004
4	Pharmaceutical PreparationsIBA 07/2009 - 11/2007
3	Immunoglobulin G (IgG)IBA 07/2019 - 11/2011
3	anti-IgE antibodiesIBA 07/2019 - 01/2013
3	Fc Receptors (Fc Receptor)IBA 07/2013 - 03/2003
3	AntigensIBA 01/2012 - 02/2006
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2012 - 03/2003
3	Heavy MetalsIBA 05/2011 - 01/2005
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2010 - 04/2009
3	AntibodiesIBA 11/2009 - 10/2008
2	AutoantibodiesIBA 07/2019 - 11/2011
2	OxazoloneIBA 03/2015 - 03/2010
2	Omalizumab (Xolair)FDA Link 05/2014 - 03/2012
2	Immunoglobulins (Immunoglobulin)IBA 01/2013 - 12/2006
2	Interleukin-8 (Interleukin 8)IBA 01/2013 - 11/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013 - 01/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2012 - 08/2012
2	Translationally-Controlled 1 Tumor ProteinIBA 11/2012 - 01/2012
2	GoldIBA 05/2011 - 06/2006
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2010 - 04/2009
2	Tryptases (Tryptase)IBA 06/2009 - 12/2007
2	SilverIBA 06/2006 - 10/2002
2	CollagenIBA 12/2005 - 02/2002
2	IgG Receptors (Fc gamma RI)IBA 12/2005 - 06/2002
1	Interleukin-17 (Interleukin 17)IBA 09/2016
1	InterleukinsIBA 09/2016
1	HaptensIBA 03/2015
1	Biological ProductsIBA 03/2015
1	Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA 09/2014
1	NeuropeptidesIBA 09/2014
1	Substance PIBA 09/2014
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2013
1	Monoclonal AntibodiesIBA 07/2013
1	Collagen Type II (Type II Collagen)IBA 07/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 03/2013
1	Stem Cell FactorIBA 03/2013
1	Superoxides (Superoxide)IBA 03/2013
1	Programmed Cell Death 1 ReceptorIBA 03/2013
1	Acyclovir (Aciclovir)FDA LinkGeneric 01/2013
1	Interleukin-33IBA 01/2013
1	Chelating AgentsIBA 01/2013
1	diallyl trisulfideIBA 12/2012
1	GalactosidasesIBA 11/2012
1	AutoantigensIBA 11/2012
1	Adenosine Triphosphate (ATP)IBA 08/2012
1	KATP ChannelsIBA 08/2012
1	Peptides (Polypeptides)IBA 01/2012
1	Nylons (Nylon)IBA 01/2012
1	LipidsIBA 12/2010
1	SalicylatesIBA 05/2010
1	Platelet Activating FactorIBA 05/2010
1	Epidermal Growth Factor (EGF)IBA 11/2009
1	AmphiregulinIBA 11/2009
1	ErbB Receptors (EGF Receptor)IBA 11/2009
1	CaspasesIBA 07/2009

Therapy/Procedure

1	Synchrotrons 01/2013
1	Replacement Arthroplasty 01/2013
1	Oral Administration 07/2009